Literature DB >> 25041320

Associations of retinal oximetry in persons with diabetes.

Ryan E K Man1, Muhammad B Sasongko, Jing Xie, Ryo Kawasaki, William J Best, Jonathan E Noonan, Chi D Luu, Jie Jin Wang, Ecosse L Lamoureux.   

Abstract

BACKGROUND: There are limited data available on the variables that might affect retinal vessel oxygen saturation (SO₂) in diabetes. Therefore, the aim of this study is to assess factors associated with retinal oximetry values in persons with diabetes.
DESIGN: Clinic-based cross-sectional study. PARTICIPANTS: Fifty-eight persons with diabetes aged 18+ years, recruited from the University of Melbourne, the Royal Victorian Eye and Ear Hospital, and St. Vincent's Hospital (Melbourne), Australia.
METHODS: Retinal oximetry was performed using the oximetry module of the Vesselmap system (Imedos UG, Jena, Germany) in 92 diabetic eyes. Generalized estimating equation models were used to estimate the associations between candidate variables (age; gender; retinal capillary flow; duration of diabetes; hypertension; smoking status; presence of diabetic retinopathy [DR]; glycated haemoglobin; triglyceride; total cholesterol; finger SO₂ and ocular perfusion pressure) with retinal oximetry measures. MAIN OUTCOME MEASURE: Arteriolar SO₂, venular SO₂ and the arterio-venous (A-V) difference.
RESULTS: Of the candidate factors assessed, only the presence of DR was significantly associated with increased venular SO₂ and decreased A-V difference in unadjusted analyses. In models adjusting for age and gender and significant variables from unadjusted analyses, compared with no DR, the presence of DR was significantly associated with greater retinal venular SO₂ values (β = 3.65%, 95% confidence interval: 0.67-6.63%) and decreased A-V difference (β = -2.00%, 95% confidence interval: -3.46 to -0.53%).
CONCLUSION: In patients with diabetes, eyes with DR were associated with increased venular SO₂ and decreased A-V difference compared with eyes without DR, suggesting an altered metabolic state in DR.
© 2014 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  diabetes; diabetic retinopathy; oxygen saturation; retinal oximetry; retinal vasculature

Mesh:

Substances:

Year:  2014        PMID: 25041320     DOI: 10.1111/ceo.12387

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  6 in total

1.  Bayer Filter Snapshot Hyperspectral Fundus Camera for Human Retinal Imaging.

Authors:  Joel Kaluzny; Hao Li; Wenzhong Liu; Peter Nesper; Justin Park; Hao F Zhang; Amani A Fawzi
Journal:  Curr Eye Res       Date:  2016-10-21       Impact factor: 2.424

Review 2.  Retinal Imaging Techniques for Diabetic Retinopathy Screening.

Authors:  James Kang Hao Goh; Carol Y Cheung; Shaun Sebastian Sim; Pok Chien Tan; Gavin Siew Wei Tan; Tien Yin Wong
Journal:  J Diabetes Sci Technol       Date:  2016-02-01

3.  Retinal oxygen extraction in individuals with type 1 diabetes with no or mild diabetic retinopathy.

Authors:  Klemens Fondi; Piotr A Wozniak; Kinga Howorka; Ahmed M Bata; Gerold C Aschinger; Alina Popa-Cherecheanu; Katarzyna J Witkowska; Anton Hommer; Doreen Schmidl; René M Werkmeister; Gerhard Garhöfer; Leopold Schmetterer
Journal:  Diabetologia       Date:  2017-05-25       Impact factor: 10.122

4.  Retinal oxygen saturation in 1461 healthy children aged 7-19 and its associated factors.

Authors:  Xiaoxiao Liu; Xiangui He; Yao Yin; Bo Zhang; Sifei Sun; Jianfeng Zhu; Haidong Zou; Ling Wang; Xun Xu
Journal:  Acta Ophthalmol       Date:  2019-02-03       Impact factor: 3.761

5.  Changes in retinal venular oxygen saturation predict activity of proliferative diabetic retinopathy 3 months after panretinal photocoagulation.

Authors:  Thomas Lee Torp; Ryo Kawasaki; Tien Yin Wong; Tunde Peto; Jakob Grauslund
Journal:  Br J Ophthalmol       Date:  2017-08-01       Impact factor: 4.638

6.  Retinal Oximetry and Vessel Diameter Measurements With a Commercially Available Scanning Laser Ophthalmoscope in Diabetic Retinopathy.

Authors:  Norman P Blair; Justin Wanek; Anthony E Felder; Charlotte E Joslin; Jacob K Kresovich; Jennifer I Lim; Felix Y Chau; Yannek Leiderman; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.